Matches in Wikidata for { <http://www.wikidata.org/entity/Q38947530> ?p ?o ?g. }
- Q38947530 description "2014 nî lūn-bûn" @default.
- Q38947530 description "2014年の論文" @default.
- Q38947530 description "2014年論文" @default.
- Q38947530 description "2014年論文" @default.
- Q38947530 description "2014年論文" @default.
- Q38947530 description "2014年論文" @default.
- Q38947530 description "2014年論文" @default.
- Q38947530 description "2014年论文" @default.
- Q38947530 description "2014年论文" @default.
- Q38947530 description "2014年论文" @default.
- Q38947530 description "2014年论文" @default.
- Q38947530 description "2014年论文" @default.
- Q38947530 description "2014年论文" @default.
- Q38947530 description "2014년 논문" @default.
- Q38947530 description "article científic" @default.
- Q38947530 description "article scientific" @default.
- Q38947530 description "article scientifique" @default.
- Q38947530 description "articol științific" @default.
- Q38947530 description "articolo scientifico" @default.
- Q38947530 description "artigo científico" @default.
- Q38947530 description "artigo científico" @default.
- Q38947530 description "artigo científico" @default.
- Q38947530 description "artikel ilmiah" @default.
- Q38947530 description "artikull shkencor" @default.
- Q38947530 description "artikulong pang-agham" @default.
- Q38947530 description "artykuł naukowy" @default.
- Q38947530 description "artículo científico publicado en 2014" @default.
- Q38947530 description "artículu científicu espublizáu en 2014" @default.
- Q38947530 description "bilimsel makale" @default.
- Q38947530 description "bài báo khoa học" @default.
- Q38947530 description "naučni članak" @default.
- Q38947530 description "scienca artikolo" @default.
- Q38947530 description "scientific article published on 15 October 2014" @default.
- Q38947530 description "scientific article published on 15 October 2014" @default.
- Q38947530 description "scientific article published on 15 October 2014" @default.
- Q38947530 description "teaduslik artikkel" @default.
- Q38947530 description "tieteellinen artikkeli" @default.
- Q38947530 description "tudományos cikk" @default.
- Q38947530 description "vedecký článok" @default.
- Q38947530 description "vetenskaplig artikel" @default.
- Q38947530 description "videnskabelig artikel" @default.
- Q38947530 description "vitenskapelig artikkel" @default.
- Q38947530 description "vitskapeleg artikkel" @default.
- Q38947530 description "vědecký článek" @default.
- Q38947530 description "wetenschappelijk artikel" @default.
- Q38947530 description "wissenschaftlicher Artikel" @default.
- Q38947530 description "επιστημονικό άρθρο" @default.
- Q38947530 description "мақолаи илмӣ" @default.
- Q38947530 description "наукова стаття, опублікована в жовтні 2014" @default.
- Q38947530 description "научна статия" @default.
- Q38947530 description "научная статья" @default.
- Q38947530 description "научни чланак" @default.
- Q38947530 description "научни чланак" @default.
- Q38947530 description "מאמר מדעי" @default.
- Q38947530 description "مقالة علمية نشرت في 15 أكتوبر 2014" @default.
- Q38947530 description "১৫ অক্টোবর ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q38947530 description "บทความทางวิทยาศาสตร์" @default.
- Q38947530 description "სამეცნიერო სტატია" @default.
- Q38947530 name "Akt-activated endothelium constitutes the niche for residual disease and resistance to bevacizumab in ovarian cancer." @default.
- Q38947530 name "Akt-activated endothelium constitutes the niche for residual disease and resistance to bevacizumab in ovarian cancer." @default.
- Q38947530 name "Akt-activated endothelium constitutes the niche for residual disease and resistance to bevacizumab in ovarian cancer." @default.
- Q38947530 type Item @default.
- Q38947530 label "Akt-activated endothelium constitutes the niche for residual disease and resistance to bevacizumab in ovarian cancer." @default.
- Q38947530 label "Akt-activated endothelium constitutes the niche for residual disease and resistance to bevacizumab in ovarian cancer." @default.
- Q38947530 label "Akt-activated endothelium constitutes the niche for residual disease and resistance to bevacizumab in ovarian cancer." @default.
- Q38947530 prefLabel "Akt-activated endothelium constitutes the niche for residual disease and resistance to bevacizumab in ovarian cancer." @default.
- Q38947530 prefLabel "Akt-activated endothelium constitutes the niche for residual disease and resistance to bevacizumab in ovarian cancer." @default.
- Q38947530 prefLabel "Akt-activated endothelium constitutes the niche for residual disease and resistance to bevacizumab in ovarian cancer." @default.
- Q38947530 P1433 Q38947530-848B5166-18CB-430A-B27B-6CE88974DC14 @default.
- Q38947530 P1476 Q38947530-8FDC8A21-6BC5-4848-BEDD-EB5B298B699F @default.
- Q38947530 P2093 Q38947530-20C2B144-4002-44AE-A258-EAE3774A676B @default.
- Q38947530 P2093 Q38947530-2A31363D-4F68-433E-AF84-52AD211BFC4E @default.
- Q38947530 P2093 Q38947530-2B46F762-231B-4398-9BA6-F4BD929D9128 @default.
- Q38947530 P2093 Q38947530-671F5173-43B0-4879-BA15-6BDE9A31B4D0 @default.
- Q38947530 P2093 Q38947530-67F96C68-DED1-43CD-9CD2-ED7777D4ECDB @default.
- Q38947530 P2093 Q38947530-730B56F9-4EE9-4C14-9C9F-52EEA6DC90E9 @default.
- Q38947530 P2093 Q38947530-82801945-AED2-4509-B2F6-4D369D252504 @default.
- Q38947530 P2093 Q38947530-968974DD-B0D1-438F-93DD-67F71B457F53 @default.
- Q38947530 P2093 Q38947530-B7DF7E0F-A5D4-49BC-839D-812B7920E8A8 @default.
- Q38947530 P2093 Q38947530-B9C76C1C-01AD-4AF6-9BFE-D178A6C09472 @default.
- Q38947530 P2093 Q38947530-FBCE35CE-C80D-4E5E-8EA8-8EFB49F39E15 @default.
- Q38947530 P2860 Q38947530-A11A542C-16A4-4188-9C05-FB483B56F751 @default.
- Q38947530 P304 Q38947530-E6BBEE02-F1D1-498C-AB55-1205C3956070 @default.
- Q38947530 P31 Q38947530-0FD1B958-473C-4411-B882-2D03408A5002 @default.
- Q38947530 P356 Q38947530-8F5885E9-FBAA-486F-9D3F-F38F19475AC4 @default.
- Q38947530 P433 Q38947530-76C35B8E-5FAF-4DCB-B85E-0A18C2601875 @default.
- Q38947530 P478 Q38947530-8D8C5FA8-3D2A-4C3C-A89A-5DB0728F2D95 @default.
- Q38947530 P50 Q38947530-621AF456-38BF-4F30-8705-A5107784FB2E @default.
- Q38947530 P50 Q38947530-9A1AF526-8CA0-4E71-9EA7-9766FA48C0DF @default.
- Q38947530 P577 Q38947530-F6D04DE8-0F6C-44F0-B02E-BDF2838EAFBF @default.
- Q38947530 P698 Q38947530-767ED37B-12B4-4062-B2C2-4B9358A9F9D2 @default.
- Q38947530 P921 Q38947530-060FEB46-1514-4676-B622-50BADC39F6BA @default.
- Q38947530 P921 Q38947530-6F3B9196-655B-4843-8FDD-E18BC2DA587B @default.
- Q38947530 P921 Q38947530-A3560967-C629-4EE5-AE73-1FBB923D8FD2 @default.
- Q38947530 P356 1535-7163.MCT-13-1053 @default.
- Q38947530 P698 25319392 @default.
- Q38947530 P1433 Q2363144 @default.
- Q38947530 P1476 "Akt-activated endothelium constitutes the niche for residual disease and resistance to bevacizumab in ovarian cancer" @default.
- Q38947530 P2093 "Amber Yasmeen" @default.
- Q38947530 P2093 "Arash Rafii" @default.